OMRT-14. Small molecule circadian clock compounds exhibit potential as a novel therapy paradigm for glioblastoma

Glioblastoma multiforme (GBM) is the most prevalent and aggressive primary brain tumor type, claiming the lives of patients within 2 years of diagnosis. The major challenges in treating GBM are largely due to the biological characteristics of the tumor and the brain and pharmacokinetics of many drug...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurooncol Adv
Autors principals: Chan, Priscilla, Hirota, Tsuyoshi, Qu, Meng, Zhang, Guoxin, Shah, Khalid, Wakimoto, Hiroaki, Kamenecka, Theodore, Solt, Laura, Rich, Jeremy, Kay, Steve
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
Supplement Abstracts
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8255417/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/noajnl/vdab070.038
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars